Journal of Affective Disorders
Volume 77, Issue 1 , Pages 21-30, October 2003

Toward the development of a Mood Disorders Insight Scale: modification of Birchwood’s Psychosis Insight Scale

  • Edward D. Sturman

      Affiliations

    • Psychopharmacology Research Program, Sunnybrook & Women’s College Health Science Centre, Toronto, Ontario, Canada
  • ,
  • Beth A. Sproule

      Affiliations

    • Psychopharmacology Research Program, Sunnybrook & Women’s College Health Science Centre, Toronto, Ontario, Canada
    • Faculty of Pharmacy and Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada
    • Corresponding Author InformationCorresponding author. Centre for Addiction and Mental Health, 33 Russell Street, Toronto, Ontario, Canada M5S 2S1. Tel.: +1-416-535-8501, ext. 6501; fax: +1-416-260-4182

Received 11 June 2001; accepted 14 January 2002.

Abstract 

Background: Insight has been defined as: (1) recognition of symptomatology, (2) the ability to attribute symptoms to a mental health disorder, and (3) complying with treatment. Insight is related to medication compliance, course of illness and outcome. Current instruments for measuring insight are limited to those that have been validated primarily in hospitalized patients with psychosis. Our objectives were to develop a reliable and valid self-report scale for use in outpatients or inpatients with mood disorders. Toward this end we made extensive revisions of the Birchwood et al. [1994, Acta Psychiatr. Scand. 89, 62] Insight Scale for Psychosis. Methods: The scale was developed by modifying items from a previous self-report scale. Specifically, assumptions of hospitalizations, psychosis, and current symptomatology were removed and items related to mood state were added. The scale was included in a battery of measures completed by outpatients and inpatients participating in a study of mood stabilizer medications. Results: Subjects (n=101, 66.3% female, median age 44 years) took approximately 2–3 min each to complete the scale. Overall scores were high (Mean=10.3 out of 12). Reliability was determined using test–retests (r=0.75, n=45). Validity testing was based mainly on clinician ratings (r=0.49, n=69). Conclusion: The new scale shows promise as a quick method for assessing insight in patients with mood disorders.

Keywords:  Insight, Mood disorders, Rating scale

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0165-0327(02)00102-7

doi:10.1016/S0165-0327(02)00102-7

Journal of Affective Disorders
Volume 77, Issue 1 , Pages 21-30, October 2003